Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: Analysis of a randomized, open-label study
Authors:
- Matthew J. ByerlyMBMatthew J. Byerly
- Ronald N. MarcusRMRonald N. Marcus
- Quynh-Van TranQTQuynh-Van Tran
- James M. EudiconeJEJames M. Eudicone
- Richard WhiteheadRWRichard Whitehead
- Ross A. BakerRBRoss A. Baker
- 1 February 2009
- journal article
- research article
- Published by Elsevier in Schizophrenia Research
- Vol. 107 (2-3) , 218-222
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Clinical Implications of Antipsychotic-Induced Hyperprolactinemia in Patients With Schizophrenia Spectrum or Bipolar Spectrum DisordersJournal of Clinical Psychopharmacology, 2007
- Reversal of Antipsychotic-Induced Hyperprolactinemia, Weight Gain, and Dyslipidemia by AripiprazoleThe Journal of Clinical Psychiatry, 2006
- Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: A pilot studyProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2006
- Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophreniaInternational Journal of Neuropsychopharmacology, 2003
- Hyperprolactinemia and Schizophrenia: Mechanisms and Clinical AspectsJournal of Psychiatric Practice, 2003
- Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trialsSchizophrenia Research, 2003
- What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?Psychoneuroendocrinology, 2003
- Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized studyPsychopharmacology, 2003
- Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective DisorderThe Journal of Clinical Psychiatry, 2002
- Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 2002